1Rebulla P, Morelati F, Revelli N,et al. Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products. Br J Haematol, 2004,125 (1): 83
2Ness PM, Campbell-Lee SA. Single donor versus pooled random donor platelet concentrates. Curr Opin Hematol, 2001,8(6) :392
3Tenorio GC, Strauss RG, Wieland MJ. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center. J Clin Apheresis, 2002,17(4) :170
4Johnson CN.The benefit of PDCA.Quality Progr,2002,35(1):120-121.
5JCAHO.Comprehensive accreditation manual for hospitals.Oakbrook Terrace:Joint Commission on Accreditation of Healthcare Organizations 2002:85.
6Bonfant G,Belfanti P,Paternoster G,et al.Clinical risk analysis with failure mode and effect analysis(FMEA)model in a dialysis unit.J Nephrol,2010,23(1):111-118.
8McDermott RE,Mikuklak RJ,Beauregard MB.The basics of FMEA.Portland:Productivity,1996.
9Lu Y,Teng F,Zhou J,et al.Failure mode and effect analysis in blood transfusion:a proactive tool to reduce risks.Transfusion,2013,53(12):3080-3087.
10Ashley L,Armitage G,Neary M,et al.A practical guide to failure mode and effects analysis in health care:making the most of the team and its meetings.Jt Commiss J Quality Patient Safety,2010,36(8):351-358.
